Embecta (EMBC) Profit After Tax Growth (1y) (2021 - 2026)
Embecta (EMBC) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 17.19% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -112.01% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -62.38% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 9.23% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 16.84% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -90.51% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -222.12% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 20.96% |
| 10 | Embecta | 204.88 Mn | 11.48 Mn | 127.80 Mn | -117.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.45% |
| Sep 30, 2025 | 80.82% |
| Jun 30, 2025 | 209.52% |
| Mar 31, 2025 | -18.69% |
| Sep 30, 2024 | 143.33% |
| Jun 30, 2024 | -3.29% |
| Mar 31, 2024 | 106.43% |
| Dec 31, 2023 | -42.90% |
| Sep 30, 2023 | 134.88% |
| Jun 30, 2023 | -75.64% |
| Mar 31, 2023 | -82.41% |
| Dec 31, 2022 | -64.37% |
| Sep 30, 2022 | -117.75% |
| Jun 30, 2022 | -40.40% |
| Mar 31, 2022 | -26.23% |
| Dec 31, 2021 | -6.17% |